| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Silvia Moga, Andreea Teodorescu, Petru Ifteni, Paula-Simina Petric, Ana-Aliana Miro. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection. Neuropsychiatric disease and treatment. vol 18. 2022-05-13. PMID:35547265. |
clozapine and neutropenia in patients with schizophrenia and sars-cov-2 infection. |
2022-05-13 |
2023-08-13 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Petru Ifteni, Paula-Simina Petric, Ana-Aliana Miro. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection. Neuropsychiatric disease and treatment. vol 18. 2022-05-13. PMID:35547265. |
clozapine (clz) is used for treatment-resistant schizophrenia (trs). |
2022-05-13 |
2023-08-13 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Petru Ifteni, Paula-Simina Petric, Ana-Aliana Miro. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection. Neuropsychiatric disease and treatment. vol 18. 2022-05-13. PMID:35547265. |
we aimed to provide a study on the association between neutropenia and clozapine in patients with schizophrenia and covid-19. |
2022-05-13 |
2023-08-13 |
Not clear |
| Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Le. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 59. 2022-05-13. PMID:35550204. |
comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: a nationwide, health insurance data-based study. |
2022-05-13 |
2023-08-13 |
Not clear |
| Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Le. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 59. 2022-05-13. PMID:35550204. |
clozapine is the most effective antipsychotic for treatment-resistant schizophrenia (trs). |
2022-05-13 |
2023-08-13 |
Not clear |
| John Holden, Milia Begu. Successful rechallenge after clozapine-associated myocarditis. BMJ case reports. vol 15. issue 5. 2022-05-13. PMID:35550318. |
clozapine is a highly effective medication used in management of treatment-resistant schizophrenia. |
2022-05-13 |
2023-08-13 |
Not clear |
| Biswa Ranjan Mishra, Kanhaiyalal Agrawal, Tathagata Biswas, Debadatta Mohapatra, Santanu Nath, Rituparna Mait. Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial. Schizophrenia bulletin. 2022-05-13. PMID:35556138. |
comparison of acute followed by maintenance ect vs clozapine on psychopathology and regional cerebral blood flow in treatment-resistant schizophrenia: a randomized controlled trial. |
2022-05-13 |
2023-08-13 |
Not clear |
| Biswa Ranjan Mishra, Kanhaiyalal Agrawal, Tathagata Biswas, Debadatta Mohapatra, Santanu Nath, Rituparna Mait. Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial. Schizophrenia bulletin. 2022-05-13. PMID:35556138. |
in treatment-resistant schizophrenia (trs), clozapine is only approved treatment with undesirable side-effects, warranting better alternatives. |
2022-05-13 |
2023-08-13 |
Not clear |
| Laurent Béchard, Mahité Morasse-Bégis, Olivier Corbeil, Joseph-Raymond Hakim, Esthel Malenfant, Sébastien Brodeur, Maxime Huot-Lavoie, Anne-Marie Essiambre, Marie-France Demers, Marc-André Ro. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series. Journal of clinical psychopharmacology. 2022-05-12. PMID:35546087. |
clozapine is the most efficacious antipsychotic for treatment-resistant schizophrenia. |
2022-05-12 |
2023-08-13 |
human |
| Gentaro Miura, Kouhei Tanaka, Takashi Kemuriyama, Fuminari Misawa, Hiroyuki Uchida, Masaru Mimura, Hiroyoshi Takeuch. Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review. Pharmacopsychiatry. 2022-05-05. PMID:35512817. |
clinical outcomes after clozapine discontinuation in patients with schizophrenia: a systematic review. |
2022-05-05 |
2023-08-13 |
Not clear |
| Gentaro Miura, Kouhei Tanaka, Takashi Kemuriyama, Fuminari Misawa, Hiroyuki Uchida, Masaru Mimura, Hiroyoshi Takeuch. Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review. Pharmacopsychiatry. 2022-05-05. PMID:35512817. |
clozapine is the gold standard of treatment for patients with treatment-resistant schizophrenia. |
2022-05-05 |
2023-08-13 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yuji Yada, Masafumi Kodama, Yoshiki Kishi, Norihito Yamad. Changes in Plasma Clozapine Levels after Smoking Cessation in Japanese Inpatients with Schizophrenia: A Retrospective Cohort Study. Acta medica Okayama. vol 76. issue 2. 2022-05-03. PMID:35503441. |
changes in plasma clozapine levels after smoking cessation in japanese inpatients with schizophrenia: a retrospective cohort study. |
2022-05-03 |
2023-08-13 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yuji Yada, Masafumi Kodama, Yoshiki Kishi, Norihito Yamad. Changes in Plasma Clozapine Levels after Smoking Cessation in Japanese Inpatients with Schizophrenia: A Retrospective Cohort Study. Acta medica Okayama. vol 76. issue 2. 2022-05-03. PMID:35503441. |
we here investigated plasma clozapine levels before and after smoking cessation in japanese inpatients with schizophrenia. |
2022-05-03 |
2023-08-13 |
Not clear |
| Masaru Tsukahara, Ryuhei So, Yuji Yada, Masafumi Kodama, Yoshiki Kishi, Norihito Yamad. Changes in Plasma Clozapine Levels after Smoking Cessation in Japanese Inpatients with Schizophrenia: A Retrospective Cohort Study. Acta medica Okayama. vol 76. issue 2. 2022-05-03. PMID:35503441. |
we conducted a retrospective chart review of 14 inpatients with schizophrenia who were being treated with clozapine between june 1, 2019, and july 31, 2019 and who were smokers as of july 1, 2019, the day on which a smoking ban was instituted in the tertiary public psychiatric hospital. |
2022-05-03 |
2023-08-13 |
Not clear |
| Amanda Seamon, Reddy Shashan. Improved MOCA Scores While on Clozapine Gains Insight into HIV. CNS spectrums. vol 27. issue 2. 2022-04-28. PMID:35477603. |
the benefit of clozapine treatment for schizophrenia patients with comorbid hiv extends beyond just symptomatic control. |
2022-04-28 |
2023-08-13 |
Not clear |
| Judith Weise, Georg Schomerus, Sven Speerforc. Add-on Cariprazine in Patients with Long-term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 20. issue 2. 2022-04-25. PMID:35466111. |
add-on cariprazine in patients with long-term clozapine treatment and treatment resistant schizophrenia: two cases of psychotic deterioration and pisa syndrome. |
2022-04-25 |
2023-08-13 |
Not clear |
| Ankita Narang, Paul Lacaze, Kathlyn J Ronaldson, John J McNeil, Mahesh Jayaram, Naveen Thomas, Rory Sellmer, David N Crockford, Robert Stowe, Steven C Greenway, Christos Pantelis, Chad A Bousma. Whole-genome sequencing analysis of clozapine-induced myocarditis. The pharmacogenomics journal. 2022-04-24. PMID:35461379. |
one of the concerns limiting the use of clozapine in schizophrenia treatment is the risk of rare but potentially fatal myocarditis. |
2022-04-24 |
2023-08-13 |
human |
| Emma Butler, Toby Pillinger, Kirsten Brown, Faith Borgan, Alice Bowen, Katherine Beck, Enrico D'Ambrosio, Lisa Donaldson, Sameer Jauhar, Stephen Kaar, Tiago Reis Marques, Robert A McCutcheon, Maria Rogdaki, Fiona Gaughran, James MacCabe, Rosalind Ramsay, David Taylor, Paul McCrone, Alice Egerton, Oliver D Howe. Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study. The British journal of psychiatry : the journal of mental science. 2022-04-19. PMID:35438068. |
clozapine is the only drug licensed for treatment-resistant schizophrenia (trs) but the real-world clinical and cost-effectiveness of community initiation of clozapine is unclear. |
2022-04-19 |
2023-08-13 |
Not clear |
| Annie Blazer, K N Roy Chengappa, William Foran, Ashley C Parr, Charles E Kahn, Beatriz Luna, Deepak K Sarpa. Changes in corticostriatal connectivity and striatal tissue iron associated with efficacy of clozapine for treatment‑resistant schizophrenia. Psychopharmacology. 2022-04-18. PMID:35435461. |
though numerous studies demonstrate the superiority of clozapine (clz) for treatment of persistent psychotic symptoms that are characteristic of treatment-refractory schizophrenia (trs), what remains unknown are the neural and molecular mechanisms underlying clz's efficacy. |
2022-04-18 |
2023-08-13 |
Not clear |
| Pasindu Wickramarachchi, Jessica M Boyd, Dennis J Orto. Biological Variation in Clozapine and Metabolite Reporting During Therapeutic Drug Monitoring. Clinica chimica acta; international journal of clinical chemistry. 2022-04-10. PMID:35398248. |
clozapine (clo) is an atypical antipsychotic used in management of treatment-resistant schizophrenia. |
2022-04-10 |
2023-08-13 |
Not clear |